课题基金 / 基金详情

COLLABORATIVE STUDIES OF NEUROENDOCRINE PHARMACOLOGY AND PHYSIOLOGY

COLLABORATIVE STUDIES OF NEUROENDOCRINE PHARMACOLOGY AND PHYSIOLOGY
神经内分泌药理学和生理学的合作研究
批准号:
3966593
负责人:
D S GOLDSTEIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

D S GOLDSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
使用我们开发的方法,我们发现所有人的血浆多巴都增加了
英文摘要
Using methodology we developed we found increased plasma DOPA in all patients studied with neuroblastoma and in most patients with malignant pheochromocytoma. DOPA, norepinephrine (NE), and dopamine (DA) are detectable in vivo in human cerebral cortex, and levels of these substances are increased in epileptogenic foci. Neuroendocrine responses to a real-life stress (removal of third molars) in humans include increases in plasma beta-endorphin NE, but only the beta-endorphin response is attenuated by pre-treatment with naloxone. Bulimics have decreased baseline levels NE, with normal responses of NE and augmented responses of heart rate to isoproterenol, suggesting decreased sympathetic neural activity and up-regulated cardiac beta-1 adrenoceptors. During surgical stress in adrenalectomized monkeys, enhanced sympathetic neural activity maintains circulatory homeostasis. Angiotensin II increases intracellular calcium and stimulates catecholamine release from cultured bovine adrenomedullary cells, providing the first demonstration that adrenomedullary cells contain functioning AII receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
  • 批准号:
    7901216
  • 项目类别:
  • 资助金额:
    $7.8万
  • 财政年份:
    2009
  • 负责人:
    D S GOLDSTEIN
  • 依托单位:
BIOCHEMICAL METHODS FOR VASOACTIVE SUBSTANCES
SYMPATHOADRENAL AND CATECHOLAMINE FUNCTION IN HEALTH
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
  • 批准号:
    8380488
  • 项目类别:
  • 资助金额:
    $7.55万
  • 财政年份:
    --
  • 负责人:
    D S GOLDSTEIN
  • 依托单位:
海外基金